NCT06595459View on ClinicalTrials.gov

The Options 2 Study

PHASE4RecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 21, 2025

Primary Completion Date

January 1, 2029

Study Completion Date

July 30, 2029

Conditions
SmokerSmoking Cessation
Interventions
DRUG

Nicotine Pouches

3mg or 6mg nicotine pouches

DRUG

Mini Nicotine lozenges

2mg to 4mg mini lozenges

Trial Locations (1)

53705

RECRUITING

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

University of Wisconsin, Madison

OTHER